Meta-analysis of ABCD Study data links genetic variants to timing of substance use initiation in adolescents.
This meta-analysis utilized longitudinal follow-up data from the Adolescent Brain Cognitive Development (ABCD) Study, which includes participants across European, African, and Hispanic ancestries. The study design treated substance use initiation timing as a time-to-event outcome, contrasting with traditional binary outcome designs often used in large-scale genetic studies. The primary outcome assessed the survival time until initiation of specific substances.
For alcohol initiation, the analysis yielded a suggestive association signal with a p-value of approximately 1 x 10^-7. Similarly, any substance use initiation showed a suggestive signal with a p-value of approximately 1 x 10^-7. Cannabis initiation also demonstrated a suggestive association signal with a p-value of approximately 5 x 10^-8. Notably, one genome-wide significant variant was identified for nicotine initiation in both fixed- and random-effects meta-analyses, with a p-value less than 5 x 10^-8.
The study did not report specific adverse events, discontinuations, or tolerability data, as these are not applicable to genetic association analyses. However, key limitations include the tendency of large-scale genetic studies to treat initiation as a binary outcome, which may underuse longitudinal timing information. Additionally, some loci exhibited cross-ancestry variation in effect estimates, and suggestive loci demonstrated limited overlap.
The practice relevance of this work demonstrates the value of incorporating developmental timing into genetic discovery. It provides a framework for integrating longitudinal risk modeling with genomic analyses, potentially refining how clinicians and researchers understand genetic contributions to substance use timing. These results highlight the need for further research to validate these associations and clarify their clinical utility.